Surveil Drug-Coated Balloon
Payments companies reported to CMS as associated with Surveil Drug-Coated Balloon. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Surveil Drug-Coated Balloon, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Surveil Drug-Coated Balloon
These are the largest totals companies reported as associated with Surveil Drug-Coated Balloon. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Schneider | Honolulu, HI | Vascular Surgery | $203,148.62 |
| David Dantzker | New York, NY | Pulmonary Disease | $12,831.21 |
| Gary Ansel | Columbus, OH | Interventional Cardiology | $400.65 |
| Kenneth Rosenfield | Boston, MA | Cardiovascular Disease | $241.15 |
| Vincent Daniel | Columbus, OH | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $23.60 |
| Fernando Rivera | Jacksonville, FL | Internal Medicine | $22.72 |
| Mark Pelka | Naperville, IL | Interventional Cardiology | $18.07 |
Prescribed Surveil Drug-Coated Balloon?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.